(Hypertension. 2008;52:123.)
© 2008 American Heart Association, Inc.
Original Articles |
From the Division of Pediatric Nephrology (J.H.W., M.P.S., A.M.), University Childrens Hospital, Heidelberg, Germany; and the Departments of Nephrology and Hypertension (K.F.H., A.H., B.K.) and Pathology (K.A.), University of Erlangen-Nuremberg, Erlangen, Germany.
Correspondence to Anette Melk, Childrens Hospital, Medical School Hannover, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany. E-mail melk.anette{at}mh-hannover.de
There is increasing evidence for a role of somatic cellular senescence in physiological aging but also in injury and disease. Cell cycle inhibitor p16INK4a is the key mediator for stress and aberrant signaling induced senescence. Here we report that elevated blood pressure markedly induced p16INK4a expression in rat kidneys and hearts, as well as in human kidneys. In kidneys from deoxycorticosterone acetate-salt–treated rats, p16INK4a induction was found in tubular, glomerular, interstitial, and vascular cells and correlated with the typical histopathologic features of hypertensive target organ damage. p16INK4a expression also correlated with phospho-p38, a positive upstream regulator of p16INK4a expression. In left ventricles, increased p16INK4a expression was found in myocardium and cardiac arteries. Antihypertensive medication consistent of hydrochlorothiazide, hydralazine, and reserpine ameliorated the histopathologic changes and attenuated p16INK4a expression in kidneys of deoxycorticosterone acetate-salt–treated rats. Nonantihypertensive administration of spironolactone also reduced kidney damage and p16INK4a expression. p16INK4a induction was further observed in kidneys from hypertensive transgenic rats heterozygous for the mouse Ren-2 gene and was prevented by the angiotensin II type 1 receptor blocker losartan. In human kidney biopsies showing hypertensive nephrosclerosis, increased p16INK4a expression was found compared with age-matched normotensive control subjects. Thus, hypertension induces cellular senescence via p16INK4a, possibly through p38, thereby contributing to hypertensive target organ damage. This detrimental effect can be overcome by different therapeutic drug strategies.
Key Words: target organ damage kidney heart senescence p16INK4a expression cell cycle inhibitor
Related Article:
Hypertension 2008 52: 61-62.
This article has been cited by other articles:
![]() |
V. A. Luyckx, C. A. Compston, T. Simmen, and T. F. Mueller Accelerated senescence in kidneys of low-birth-weight rats after catch-up growth Am J Physiol Renal Physiol, December 1, 2009; 297(6): F1697 - F1705. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Anderson, J. B. Halter, W. R. Hazzard, J. Himmelfarb, F. M. Horne, G. A. Kaysen, J. W. Kusek, S. G. Nayfield, K. Schmader, Y. Tian, et al. Prediction, Progression, and Outcomes of Chronic Kidney Disease in Older Adults J. Am. Soc. Nephrol., June 1, 2009; 20(6): 1199 - 1209. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. E. Mann What's new in hypertension 2008? Nephrol. Dial. Transplant., January 1, 2009; 24(1): 38 - 42. [Full Text] [PDF] |
||||
![]() |
M. W. Bergmann, L. Zelarayan, and C. Gehrke Treatment-Sensitive Premature Renal and Heart Senescence in Hypertension Hypertension, July 1, 2008; 52(1): 61 - 62. [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |